Filing Details

Accession Number:
0001562180-18-003488
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-03 19:35:43
Reporting Period:
2018-08-02
Accepted Time:
2018-08-03 19:35:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640771 M. Chris Calcaterra C/O Glaukos Corporation
229 Avenida Fabricante
San Clemente CA 92672
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-02 38,983 $16.49 278,983 No 4 M Direct
Common Stock Disposition 2018-08-02 34,361 $44.31 244,622 No 4 S Direct
Common Stock Disposition 2018-08-02 4,522 $45.40 240,100 No 4 S Direct
Common Stock Disposition 2018-08-02 100 $46.29 240,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Disposition 2018-08-02 38,983 $0.00 38,983 $16.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,417 2026-03-10 No 4 M Direct
Footnotes
  1. These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
  2. This transaction was executed in multiple trades at prices ranging from $44.00 to $44.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $45.00 to $45.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.